Updates on antibody-mediated rejection in intestinal transplantation.

PubWeight™: 0.76‹?›

🔗 View Article (PMID 27683635)

Published in World J Transplant on September 24, 2016

Authors

Guo-Sheng Wu1

Author Affiliations

1: Guo-Sheng Wu, Division of Gastrointestinal Surgery, Xijing Hospital of Digestive Diseases, the Fourth Military Medical University, Xi'an 710032, Shannxi Province, China.

Articles cited by this

Significance of the positive crossmatch test in kidney transplantation. N Engl J Med (1969) 5.50

Understanding the causes of kidney transplant failure: the dominant role of antibody-mediated rejection and nonadherence. Am J Transplant (2011) 4.06

Consensus guidelines on the testing and clinical management issues associated with HLA and non-HLA antibodies in transplantation. Transplantation (2013) 2.55

Intestinal transplantation. N Engl J Med (2009) 2.20

National conference to assess antibody-mediated rejection in solid organ transplantation. Am J Transplant (2004) 2.01

Pathology of human intestinal transplantation. Gastroenterology (1996) 1.98

Single human leukocyte antigen flow cytometry beads for accurate identification of human leukocyte antigen antibody specificities. Transplantation (2003) 1.80

Mucosal vascular alterations in isolated small-bowel allografts: relationship to humoral sensitization. Am J Transplant (2003) 1.64

Diagnosis and management of antibody-mediated rejection: current status and novel approaches. Am J Transplant (2014) 1.29

Intestinal and multivisceral transplantation in children. Ann Surg (2006) 1.22

Five hundred intestinal and multivisceral transplantations at a single center: major advances with new challenges. Ann Surg (2009) 1.21

Pretransplant predictors of survival after intestinal transplantation: analysis of a single-center experience of more than 100 transplants. Transplantation (2010) 1.13

Donor-specific antibodies in allograft recipients: etiology, impact and therapeutic approaches. Curr Opin Organ Transplant (2014) 1.00

Isolated donor specific alloantibody-mediated rejection after ABO compatible liver transplantation. Am J Transplant (2006) 1.00

Preformed and de novo donor specific antibodies in visceral transplantation: long-term outcome with special reference to the liver. Am J Transplant (2012) 0.97

Intestinal transplant registry report: global activity and trends. Am J Transplant (2014) 0.96

Association between donor-specific antibodies and acute rejection and resolution in small bowel and multivisceral transplantation. Transplantation (2011) 0.95

Evaluation of C4d staining in liver and small intestine allografts. Arch Pathol Lab Med (2006) 0.94

The current state of intestine transplantation: indications, techniques, outcomes and challenges. Am J Transplant (2014) 0.93

An updated Banff schema for diagnosis of antibody-mediated rejection in renal allografts. Curr Opin Organ Transplant (2014) 0.89

Correlation of donor-specific antibodies, complement and its regulators with graft dysfunction in cardiac antibody-mediated rejection. Am J Transplant (2009) 0.89

Emerging role of donor-specific anti-human leukocyte antigen antibody determination for clinical management after solid organ transplantation. Hum Immunol (2009) 0.89

Organ Procurement and Transplantation Network/Scientific Registry of Transplant Recipients 2014 Data Report: Intestine. Clin Transpl (2014) 0.88

Intestine and multivisceral transplantation: current status and future directions. Curr Gastroenterol Rep (2015) 0.86

Acute humoral rejection of human lung allografts and elevation of C4d in bronchoalveolar lavage fluid. Am J Transplant (2004) 0.85

Evaluation of c4d deposition and circulating antibody in small bowel transplantation. Am J Transplant (2008) 0.84

Antibody-mediated rejection in liver transplantation: current controversies and future directions. Liver Transpl (2014) 0.83

Antibody-mediated rejection of a pancreas allograft. Am J Transplant (2006) 0.83

Successful isolated intestinal transplantation in sensitized recipients with the use of virtual crossmatching. Am J Transplant (2012) 0.83

Immunological status of isolated lymphoid follicles after intestinal transplantation. Am J Transplant (2014) 0.82

The impact of positive T-cell lymphocytotoxic crossmatch on intestinal allograft rejection and survival. Transplant Proc (2000) 0.82

Antibody-mediated rejection after intestinal transplantation. Curr Opin Organ Transplant (2012) 0.82

Antibody-mediated rejection. Curr Opin Organ Transplant (2015) 0.82

Impact of positive flow cytometry crossmatch on outcomes of intestinal/multivisceral transplantation: role anti-IL-2 receptor antibody. Transplantation (2013) 0.81

Combined living donor liver/small bowel transplantation. Transplantation (2005) 0.81

Immunologic challenges in small bowel transplantation. Am J Transplant (2012) 0.81

Clinical relevance of the de novo production of anti-HLA antibodies following intestinal and multivisceral transplantation. Transpl Int (2014) 0.81

Treatment of hyperacute antibody-mediated lung allograft rejection with eculizumab. J Heart Lung Transplant (2012) 0.80

Current understanding of alloimmunity of the intestinal graft. Curr Opin Organ Transplant (2015) 0.79

The use of circulating donor specific antibody to predict biopsy diagnosis of antibody-mediated rejection and to provide prognostic value after heart transplantation in children. J Heart Lung Transplant (2015) 0.79

Immediate antibody-mediated (hyperacute) rejection in small-bowel transplantation and relationship to cross-match status and donor-specific C4d-binding antibodies: case report. Transplant Proc (2010) 0.79

Intestinal transplantation: current outcomes and opportunities. Curr Opin Organ Transplant (2009) 0.79

A clinicopathologic study of isolated intestinal allografts with preformed IgG lymphocytotoxic antibodies. Hum Pathol (2004) 0.79

Liver inclusion improves outcomes of intestinal retransplantation in adults. [Corrected]. Transplantation (2015) 0.78

Salvage therapy for refractory rejection and persistence of donor-specific antibodies after intestinal transplantation using the proteasome inhibitor bortezomib. Transpl Int (2010) 0.77

The Challenge of Acute Antibody-Mediated Rejection in Kidney Transplantation. Transplantation (2016) 0.77

Eculizumab Salvage Therapy for Antibody-Mediated Rejection in a Desensitization-Resistant Intestinal Re-Transplant Patient. Am J Transplant (2015) 0.77

Successful living donor intestinal transplantation in cross-match positive recipients: Initial experience. World J Gastrointest Surg (2016) 0.76

The Role of Donor-Specific Antibodies in Intestinal Transplantation: Experience at the University of California Los Angeles and Literature Review. Clin Transpl (2014) 0.76

Donor-specific human leukocyte antigen antibodies in intestinal transplantation. Curr Opin Organ Transplant (2014) 0.76

Histologic analysis of chronic rejection in small bowel transplantation: mucosal and vascular alterations. Transplantation (2013) 0.76

Mechanism, pathophysiology, diagnosis, and management of renal transplant rejection. Med Clin North Am (1990) 0.76